Gastro-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Rabeprazole 20 mg, designed for the effective management of gastrointestinal disorders characterized by acid reflux, dyspepsia, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Rabeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing symptomatic relief from acid-related disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The synergistic action of these agents in Gastro-DSR Capsule offers comprehensive management of upper gastrointestinal symptoms by both enhancing motility and reducing acid secretion. This combination is indicated for patients with symptomatic GERD, erosive esophagitis, and functional dyspepsia where acid suppression and prokinetic effects are clinically warranted. Gastro-DSR Capsule should be administered under medical supervision, with dosage adjustments based on clinical response and tolerability. Caution is advised in patients with underlying cardiac conditions or those taking medications that may interact with domperidone or rabeprazole.